Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
15,247
datasets available to search
ShareScore release 0.9.0
Dataset results
15,247 results for “Breast Cancer”
A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients
ClinicalTrials.gov study NCT03983382. IPD Sharing: YES. Countries: 1. Publications: 1.
Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer, a Randomized Controlled Trial
ClinicalTrials.gov study NCT03783546. IPD Sharing: YES. Countries: 1. Publications: 1.
Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT03096847. IPD Sharing: YES. Countries: 1. Publications: 1.
Lapatinib and Bevacizumab for Metastatic Breast Cancer
ClinicalTrials.gov study NCT00444535. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer
ClinicalTrials.gov study NCT01958021. IPD Sharing: YES. Countries: 29. Publications: 12.
Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer
ClinicalTrials.gov study NCT00195091. IPD Sharing: YES. Countries: 1. Publications: 1.
Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer
ClinicalTrials.gov study NCT04059484. IPD Sharing: YES. Countries: 23. Publications: 1.
Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT02980341. IPD Sharing: YES. Countries: 2. Publications: 1.
A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
ClinicalTrials.gov study NCT01633060. IPD Sharing: UNDECIDED. Countries: 22. Publications: 1.
NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer
ClinicalTrials.gov study NCT03789110. IPD Sharing: YES. Countries: 1. Publications: 1.
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progres
ClinicalTrials.gov study NCT03056755. IPD Sharing: YES. Countries: 19. Publications: 4.
Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00876395. IPD Sharing: UNDECIDED. Countries: 28. Publications: 3.
Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer
ClinicalTrials.gov study NCT03284957. IPD Sharing: YES. Countries: 10. Publications: 1.
Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China
ClinicalTrials.gov study NCT00508274. IPD Sharing: YES. Countries: 2. Publications: 1.
Telephone Support for Metastatic Breast Cancer Patients
ClinicalTrials.gov study NCT03998618. IPD Sharing: YES. Countries: 1. Publications: 1.
Reproducible data, example subsets, and analysis pipeline for the extended TAaCGH study of breast cancer genomic and transcriptomic profiles
Open the record for dataset details and reuse information.
Data from: Screening familial risk for hereditary breast and ovarian cancer
Open the record for dataset details and reuse information.
Feasibility and acceptability of personalized breast cancer screening (DECIDO Study): A single-arm proof-of-concept trial
Open the record for dataset details and reuse information.
Data from: Identification of a minority population of LMO2+ breast cancer cells that integrate into the vasculature and initiate metastasis.
Open the record for dataset details and reuse information.
Effects of Tamoxifen on the Reproductive System of Females with Breast Cancer
<p><strong>Background: </strong>Tamoxifen (TMX) currently regarded as the standard treatment for breast cancer (BC) patients‎, however in recent years, several researchers reported gynecological side effects and attributed them to TMX and its estrogenic (ER) effects. We evaluate the side effects of TMX on female ‎endometrium and ovaries.</p> <p><strong>Methods:</strong> an ultrasound-based cohort study conducted in three oncology centers. The studied groups included a total of ‎‎255 patients, 140 premenopausal (PreM) and 115 postmenopausal (PostM) female patients with ER-positive BC using TMX adjuvant hormonal treatment in ‎a dose of 20 mg/day for at least three months after surgery and adjuvant ‎chemo/radiotherapy.‎ The study conducted at the three main oncology centers in Baghdad. The collected data includes: age of the patient, menopausal status, co-morbid chronic illness such as hypertension, diabetes mellitus, etc, and used medications.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.